Neurotoxins
Botulinum toxin products used in aesthetic and therapeutic medicine, including approvals, labelling and safety communications.
- Editorial attention
- Quiet
- Tracked this week
- 0
- Sources this week
- 0
- Last activity
- —
Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
Neurotoxins at a glance
- About this topic
- Botulinum toxin products used in aesthetic and therapeutic medicine, including approvals, labelling and safety communications.
- Current status
- No editor-reviewed status summary yet. The official records below update automatically.
- Key facts from tracked records
- 20 clinical trials tracked from ClinicalTrials.gov
What’s the latest on Neurotoxins?
0 totalNo briefings on this topic yet. Official records and trials below are updated continuously.
What do the official records show?
Primary sources and peer-reviewed researchNo official records linked to this topic yet.
Which clinical trials are being tracked?
All trials- Treatment for "Asymmetric Crying Facies"
Xiaolei Jin. Conditions: Hemifacial Microsomia; Facial Nerve Paralysis. Investigational — not approved for the use studied.
- A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
AbbVie. Conditions: Glabellar Lines. Results posted 2026-09-25. Investigational — not approved for the use studied.
- Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd.. Conditions: Moderate to Severe Glabellar Lines. Investigational — not approved for the use studied.
- PLATINUM EU: A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
Merz Aesthetics GmbH. Conditions: Neuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholine Release Inhibit…. Investigational — not approved for the use studied.
- PLATINUM US: A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
Merz North America, Inc.. Conditions: Neuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholine Release Inhibit…. Investigational — not approved for the use studied.
- A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
AbbVie. Conditions: Glabellar Lines. Investigational — not approved for the use studied.